Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA NATCO PHARMA ASTRAZENECA PHARMA/
NATCO PHARMA
 
P/E (TTM) x 95.5 13.3 715.9% View Chart
P/BV x 22.7 3.5 649.0% View Chart
Dividend Yield % 0.3 0.6 52.0%  

Financials

 ASTRAZENECA PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
NATCO PHARMA
Mar-23
ASTRAZENECA PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs3,620847 427.5%   
Low Rs2,438502 485.6%   
Sales per share (Unadj.) Rs401.2148.4 270.4%  
Earnings per share (Unadj.) Rs39.739.2 101.3%  
Cash flow per share (Unadj.) Rs46.248.2 95.9%  
Dividends per share (Unadj.) Rs16.005.50 290.9%  
Avg Dividend yield %0.50.8 64.8%  
Book value per share (Unadj.) Rs234.4267.1 87.8%  
Shares outstanding (eoy) m25.00182.47 13.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.54.5 166.1%   
Avg P/E ratio x76.317.2 443.3%  
P/CF ratio (eoy) x65.514.0 468.2%  
Price / Book Value ratio x12.92.5 511.7%  
Dividend payout %40.314.0 287.1%   
Avg Mkt Cap Rs m75,718123,049 61.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2,5914,867 53.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,03027,071 37.0%  
Other income Rs m2611,285 20.3%   
Total revenues Rs m10,29128,356 36.3%   
Gross profit Rs m1,2499,117 13.7%  
Depreciation Rs m1631,638 9.9%   
Interest Rs m6145 4.3%   
Profit before tax Rs m1,3418,619 15.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3481,466 23.7%   
Profit after tax Rs m9937,153 13.9%  
Gross profit margin %12.533.7 37.0%  
Effective tax rate %26.017.0 152.6%   
Net profit margin %9.926.4 37.5%  
BALANCE SHEET DATA
Current assets Rs m9,35930,003 31.2%   
Current liabilities Rs m4,8446,831 70.9%   
Net working cap to sales %45.085.6 52.6%  
Current ratio x1.94.4 44.0%  
Inventory Days Days4963 77.9%  
Debtors Days Days39115 33.9%  
Net fixed assets Rs m2,06126,571 7.8%   
Share capital Rs m50365 13.7%   
"Free" reserves Rs m5,81148,373 12.0%   
Net worth Rs m5,86148,738 12.0%   
Long term debt Rs m00-   
Total assets Rs m11,42156,574 20.2%  
Interest coverage x213.960.4 353.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.5 183.5%   
Return on assets %8.712.9 67.8%  
Return on equity %16.914.7 115.4%  
Return on capital %23.018.0 127.8%  
Exports to sales %00-   
Imports to sales %37.410.2 364.8%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m3,7472,772 135.2%   
Fx inflow Rs m61217,256 3.5%   
Fx outflow Rs m3,7472,772 135.2%   
Net fx Rs m-3,13514,484 -21.6%   
CASH FLOW
From Operations Rs m5838,491 6.9%  
From Investments Rs m181-4,771 -3.8%  
From Financial Activity Rs m-245-3,630 6.7%  
Net Cashflow Rs m519208 249.6%  

Share Holding

Indian Promoters % 0.0 49.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 5.4 25.0 21.7%  
FIIs % 2.7 13.7 19.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 50.3 49.7%  
Shareholders   29,032 207,571 14.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Natco Pharma Share Price Performance

Period ASTRAZENECA PHARMA Natco Pharma S&P BSE HEALTHCARE
1-Day 0.01% -2.11% 1.18%
1-Month -3.61% -3.19% -0.75%
1-Year 59.20% 72.80% 61.82%
3-Year CAGR 20.50% 4.96% 18.16%
5-Year CAGR 22.18% 10.96% 19.79%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Natco Pharma the stake stands at 49.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

Natco Pharma paid Rs 5.5, and its dividend payout ratio stood at 14.0%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.